Literature DB >> 2406855

Diarrhea in developed and developing countries: magnitude, special settings, and etiologies.

R L Guerrant1, J M Hughes, N L Lima, J Crane.   

Abstract

Diarrheal diseases are major causes of morbidity, with attack rates ranging from two to 12 or more illnesses per person per year in developed and developing countries. In addition, diarrheal illnesses account for an estimated 12,600 deaths each day in children in Asia, Africa, and Latin America. The causes of diarrhea include a wide array of viruses, bacteria, and parasites, many of which have been recognized only in the last decade or two. While enterotoxigenic Escherichia coli and rotaviruses predominate in developing areas, Norwalk-like viruses, Campylobacter jejuni, and cytotoxigenic Clostridium difficile are seen with increasing frequency in developed areas; and Shigella, Salmonella, Cryptosporidium species, and Giardia lamblia are found throughout the world. The rational management of infectious diarrhea requires the highly selective use of laboratory tests for these varied etiologic agents, depending on the clinical and epidemiologic setting. The purpose of this review is to provide an overview of the magnitude, special settings, and etiologies of diarrhea endemic to developed and developing countries. This information permits a practical approach to the diagnosis and management of common diarrheal illnesses in different settings.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Adult; Age Factors; Aged; Americas; Behavior; Child Care; Child Rearing; Delivery Of Health Care; Demographic Factors; Developed Countries; Developing Countries; Diarrhea--etiology; Diseases; Epidemics; Family And Household; Family Characteristics; Health; Health Facilities; Hiv Infections; Hospitals; Morbidity; North America; Northern America; Nuclear Family; Ohio; Population; Population Characteristics; United States; Viral Diseases; Virginia

Mesh:

Year:  1990        PMID: 2406855      PMCID: PMC7792920          DOI: 10.1093/clinids/12.supplement_1.s41

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  105 in total

1.  Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.

Authors:  Kim L Credito; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Genetic diversity of norovirus among children with gastroenteritis in São Paulo State, Brazil.

Authors:  Juliana Galera Castilho; Veridiana Munford; Hugo Reis Resque; Ulysses Fagundes-Neto; Jan Vinjé; Maria Lúcia Rácz
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

3.  Discovery of novel secreted virulence factors from Salmonella enterica serovar Typhimurium by proteomic analysis of culture supernatants.

Authors:  George S Niemann; Roslyn N Brown; Jean K Gustin; Afke Stufkens; Afshan S Shaikh-Kidwai; Jie Li; Jason E McDermott; Heather M Brewer; Athena Schepmoes; Richard D Smith; Joshua N Adkins; Fred Heffron
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 4.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 5.  Quinolones in the treatment of acute bacterial diarrhoeal diseases.

Authors:  H E Akalin
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Antimicrobial resistance and management of invasive Salmonella disease.

Authors:  Samuel Kariuki; Melita A Gordon; Nicholas Feasey; Christopher M Parry
Journal:  Vaccine       Date:  2015-04-23       Impact factor: 3.641

7.  Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.

Authors:  T Louie; M Miller; C Donskey; K Mullane; E J C Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Three-year prevalence of enteropathogenic bacteria in an urban patient population in Germany.

Authors:  O Liesenfeld; T Weinke; H Hahn
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.

Authors:  S S Johal; C P Lambert; J Hammond; P D James; S P Borriello; Y R Mahida
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

10.  Role of retinol in protecting epithelial cell damage induced by Clostridium difficile toxin A.

Authors:  Andressa A F L Maciel; Reinaldo B Oriá; Manuel B Braga-Neto; Andréa B Braga; Eunice B Carvalho; Herene B M Lucena; Gerly A C Brito; Richard L Guerrant; Aldo A M Lima
Journal:  Toxicon       Date:  2007-07-31       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.